PACIRA BIOSCIENCES IN

Third Circuit Court Upholds Decision to Dismiss Pacira BioSciences, Inc. Lawsuit

27 мар 2023 08:00:00 Источник Nasdaq GlobeNewswire

Pacira BioSciences Announces Yvonne Greenstreet to Retire from Board of Directors

22 мар 2023 08:00:01 Источник Nasdaq GlobeNewswire

Pacira BioSciences to Participate in Fireside Chat at the 2023 Barclays Global Healthcare Conference

08 мар 2023 08:00:01 Источник Nasdaq GlobeNewswire

Pacira BioSciences Reports Full-Year and Fourth Quarter 2022 Financial Results

28 фев 2023 08:00:03 Источник Nasdaq GlobeNewswire

LPGA, Pacira BioSciences Partner to Raise Awareness of Non-Opioid Pain Management Solutions

23 фев 2023 08:00:02 Источник Nasdaq GlobeNewswire

Pacira BioSciences Reports Preliminary Unaudited Total Revenue for 2022 of $666.8 Million

05 янв 2023 16:30:00 Источник Nasdaq GlobeNewswire

Pacira BioSciences to Present at the 41st Annual J.P. Morgan Healthcare Conference

04 янв 2023 08:00:01 Источник Nasdaq GlobeNewswire

Pacira BioSciences Reports Preliminary Net Product Sales of $57.5 Million for November 2022

13 дек 2022 08:00:02 Источник Nasdaq GlobeNewswire

Pacira BioSciences Reports Preliminary Net Product Sales of $54.9 Million for October 2022

14 ноя 2022 08:00:01 Источник Nasdaq GlobeNewswire

Pacira BioSciences to Present at Two Healthcare Conferences in November

08 ноя 2022 08:00:03 Источник Nasdaq GlobeNewswire

Pacira BioSciences Reports Third Quarter 2022 Financial Results

03 ноя 2022 08:00:02 Источник Nasdaq GlobeNewswire

Pacira to Report Third Quarter 2022 Financial Results on Thursday November 3, 2022

20 окт 2022 08:00:03 Источник Nasdaq GlobeNewswire

Pacira BioSciences Reports Preliminary Third Quarter 2022 Revenue of $167.5 Million

13 окт 2022 08:00:01 Источник Nasdaq GlobeNewswire

Sevāredent Sourcing Solutions and Pacira BioSciences Collaborate to Provide Expanded Access to EXPAREL for Patients Undergoing Oral and Maxillofacial Procedures

27 сен 2022 08:00:00 Источник Nasdaq GlobeNewswire

Pacira BioSciences Announces Positive Topline Data from Phase 3 Study of EXPAREL as a Single-dose Sciatic Nerve Block in the Popliteal Fossa for Bunionectomy

21 сен 2022 08:00:01 Источник Nasdaq GlobeNewswire

Pacira Receives Positive CHMP Opinion for EXPAREL® for the Treatment of Postsurgical Pain in Children Aged 6 or Older

20 сен 2022 08:00:01 Источник Nasdaq GlobeNewswire

Pacira BioSciences Reports Preliminary Net Product Sales of $59.1 Million for August 2022

13 сен 2022 08:00:01 Источник Nasdaq GlobeNewswire

Pacira BioSciences Announces Positive Topline Data from Phase 3 Study of EXPAREL as a Single-dose Femoral Nerve Block in the Adductor Canal for Total Knee Arthroplasty

07 сен 2022 07:00:01 Источник Nasdaq GlobeNewswire

Pacira BioSciences Reports Preliminary Net Product Sales of $50.2 Million for July 2022

10 авг 2022 08:00:01 Источник Nasdaq GlobeNewswire

NFL Alumni Association and Pacira BioSciences Team Up to Educate Athletes and Communities About Non-Opioid Options to Manage Pain

09 авг 2022 07:30:00 Источник Nasdaq GlobeNewswire